Patrick Campbell

Investigators observed a 22% and 20% increased risk of heart failure during the 2 most severe influenza seasons.

Siponimod becomes first oral drug to treat secondary progressive MS to receive FDA approval.

More than 80% of patients saw maintenance or improvement of BCVA, with a mean improvment of 7 letters or more, according to the ETDRS system.

Aimmune announced AR101 phase 3 trial reached its primary efficacy endpoint, intent to submit marketing authorization application.

No significant differences in cardiovascular outcomes among patients receiving different GLP-1 agonists including exenatide extended-release, exenatide immediate-release, liraglutide, albiglutide, and dulaglutide.

Over the course of 16 weeks, OSA patients receiving CPAP treatment lost 5.7 pounds more on average than patients not receving CPAP therapy.

First RCT to determine the efficacy of wearable digital intervention to improve social behavior of children with autism spectrum disorder.

The Apple Heart Study examined more than 400,000 patients over the course of a year, but some experts were less than thrilled with the outcomes.

Study of Danish children finds that onset of maternal mental illness increases a child's risk of not completing primary education.

The dual-acting dopamine and norepinephrine reuptake inhibitor is the first approved to treat excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea.

A new study of more than 300000 women finds their may be a link between higher BMI at puberty and development of MS.

Study finds that cardiovascular disease accounts for almost 40% of deaths in young adults with end-stage renal disease.

Observed data from a 96,000-plus participant survey found the popularized cigarette alternative is also associated with a greater risk of depression.

A new study of a blood pressure-monitoring mobile app reports patients with diabetes could reach better thresholds.

A 5000-plus patient study found that about 80% of young women have never been administered a lipid test.

The rate of heart attacks among patients under 40 years old has been increasing by 2% annually for the past decade.

The ACC, in conjunction with the AHA and Heart Rhythm Association, released their 2019 guideline for the management of patients with atrial fibrillation.

FDA approved Rocklatan, a once-daily eye drop produced by Aerie Pharmaceuticals Inc., for patients with open-angle glaucoma or ocular hypertension.

University of Colorado study finds choline can help prevent fetal brain development problems in expecting mothers who experience illness.

Physicians found bempedoic acid was capable of reducing LDL-C by another 18% without muscle or liver issues due to high-dose statin regimen.

A review of suicide prediction models reveals limited practical application on larger populations.

Despite previous observations that high-quality diet correlates to lower depression symptoms, new results paint a different picture.